1
Drugs.com: Pandemic disrupting lung cancer screening
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 5, 2021
Drugs.com reports that COVID-19 has caused significant disruption in lung cancer screening.
January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.